News Image

Editas Medicine to Participate in Upcoming Investor Conferences

Provided By GlobeNewswire

Last update: Aug 27, 2025

CAMBRIDGE, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneering gene editing company focused on developing transformative medicines for serious diseases, today announced that management will participate in the following upcoming investor conferences in September:

Read more at globenewswire.com

EDITAS MEDICINE INC

NASDAQ:EDIT (10/27/2025, 2:34:55 PM)

3.29

-0.43 (-11.56%)



Find more stocks in the Stock Screener

EDIT Latest News and Analysis

Follow ChartMill for more